Did the covid-19 pandemic delay treatment for localized breast cancer patients? a multicenter study

HIGHLIGHTS

• What: Regarding breast cancer (BC), which is the focus of the study presented below, essential surgical (i.e., oncologic surgery) and medical oncology were not suspended. For patients with NACT, it equalled d1 COVID-19 and treatment delay in breast cancer patients +d2+d3 (i.e., excluding NACT duration: N1+ N2 from the delay to surgery, as the authors focused only on lag time without ongoing treatment), as shown in the red dashed line in Fig 1. The authors demonstrated that the COVID-19 pandemic did not change the delay to treatment in newly diagnosed patients with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.